HOCPY
Price
$132.75
Change
+$5.74 (+4.52%)
Updated
Aug 8 closing price
Capitalization
45.21B
85 days until earnings call
TRUMY
Price
$18.60
Change
-$0.07 (-0.37%)
Updated
Aug 8 closing price
Capitalization
27.47B
87 days until earnings call
Interact to see
Advertisement

HOCPY vs TRUMY

Header iconHOCPY vs TRUMY Comparison
Open Charts HOCPY vs TRUMYBanner chart's image
Hoya
Price$132.75
Change+$5.74 (+4.52%)
Volume$18.62K
Capitalization45.21B
Terumo
Price$18.60
Change-$0.07 (-0.37%)
Volume$158.26K
Capitalization27.47B
HOCPY vs TRUMY Comparison Chart in %
Loading...
HOCPY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRUMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOCPY vs. TRUMY commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOCPY is a Hold and TRUMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (HOCPY: $132.75 vs. TRUMY: $18.60)
Brand notoriety: HOCPY and TRUMY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HOCPY: 64% vs. TRUMY: 61%
Market capitalization -- HOCPY: $45.21B vs. TRUMY: $27.47B
HOCPY [@Pharmaceuticals: Other] is valued at $45.21B. TRUMY’s [@Pharmaceuticals: Other] market capitalization is $27.47B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $168.51B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOCPY’s FA Score shows that 0 FA rating(s) are green whileTRUMY’s FA Score has 0 green FA rating(s).

  • HOCPY’s FA Score: 0 green, 5 red.
  • TRUMY’s FA Score: 0 green, 5 red.
According to our system of comparison, TRUMY is a better buy in the long-term than HOCPY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOCPY’s TA Score shows that 7 TA indicator(s) are bullish while TRUMY’s TA Score has 4 bullish TA indicator(s).

  • HOCPY’s TA Score: 7 bullish, 3 bearish.
  • TRUMY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, HOCPY is a better buy in the short-term than TRUMY.

Price Growth

HOCPY (@Pharmaceuticals: Other) experienced а +13.36% price change this week, while TRUMY (@Pharmaceuticals: Other) price change was +9.41% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.86%. For the same industry, the average monthly price growth was -3.35%, and the average quarterly price growth was +2.88%.

Reported Earning Dates

HOCPY is expected to report earnings on Nov 04, 2025.

TRUMY is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+1.86% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HOCPY($45.2B) has a higher market cap than TRUMY($27.5B). TRUMY (34.66) and HOCPY (33.62) have similar P/E ratio . HOCPY YTD gains are higher at: 7.056 vs. TRUMY (-4.615). HOCPY has higher annual earnings (EBITDA): 310B vs. TRUMY (247B). HOCPY has more cash in the bank: 539B vs. TRUMY (195B). HOCPY has less debt than TRUMY: HOCPY (37.3B) vs TRUMY (175B). TRUMY has higher revenues than HOCPY: TRUMY (987B) vs HOCPY (886B).
HOCPYTRUMYHOCPY / TRUMY
Capitalization45.2B27.5B164%
EBITDA310B247B126%
Gain YTD7.056-4.615-153%
P/E Ratio33.6234.6697%
Revenue886B987B90%
Total Cash539B195B276%
Total Debt37.3B175B21%
FUNDAMENTALS RATINGS
HOCPY vs TRUMY: Fundamental Ratings
HOCPY
TRUMY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
38
Fair valued
PROFIT vs RISK RATING
1..100
6697
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
4751
P/E GROWTH RATING
1..100
6040
SEASONALITY SCORE
1..100
5014

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TRUMY's Valuation (38) in the null industry is somewhat better than the same rating for HOCPY (76). This means that TRUMY’s stock grew somewhat faster than HOCPY’s over the last 12 months.

HOCPY's Profit vs Risk Rating (66) in the null industry is in the same range as TRUMY (97). This means that HOCPY’s stock grew similarly to TRUMY’s over the last 12 months.

HOCPY's SMR Rating (99) in the null industry is in the same range as TRUMY (99). This means that HOCPY’s stock grew similarly to TRUMY’s over the last 12 months.

HOCPY's Price Growth Rating (47) in the null industry is in the same range as TRUMY (51). This means that HOCPY’s stock grew similarly to TRUMY’s over the last 12 months.

TRUMY's P/E Growth Rating (40) in the null industry is in the same range as HOCPY (60). This means that TRUMY’s stock grew similarly to HOCPY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HOCPYTRUMY
RSI
ODDS (%)
Bearish Trend 4 days ago
64%
Bearish Trend 4 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
61%
Bearish Trend 4 days ago
65%
Momentum
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
71%
MACD
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
63%
Bullish Trend 4 days ago
65%
Advances
ODDS (%)
Bullish Trend 6 days ago
66%
Bullish Trend 5 days ago
67%
Declines
ODDS (%)
Bearish Trend 13 days ago
67%
Bearish Trend 12 days ago
63%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
74%
Aroon
ODDS (%)
Bullish Trend 4 days ago
64%
Bearish Trend 4 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
HOCPY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRUMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRCT0.420.02
+4.14%
Direct Digital Holdings
MYGN6.320.22
+3.61%
Myriad Genetics
DGX176.962.69
+1.54%
Quest Diagnostics
CWT46.78-0.10
-0.21%
California Water Service
SVCO4.01-0.15
-3.61%
Silvaco Group Inc

HOCPY and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOCPY has been loosely correlated with TRUMY. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if HOCPY jumps, then TRUMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOCPY
1D Price
Change %
HOCPY100%
+4.52%
TRUMY - HOCPY
51%
Loosely correlated
-0.37%
SSMXY - HOCPY
44%
Loosely correlated
+0.80%
OLYMY - HOCPY
32%
Poorly correlated
-1.32%
HOCPF - HOCPY
27%
Poorly correlated
+10.84%
STSS - HOCPY
27%
Poorly correlated
+30.00%
More

TRUMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRUMY has been loosely correlated with HOCPY. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TRUMY jumps, then HOCPY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRUMY
1D Price
Change %
TRUMY100%
-0.37%
HOCPY - TRUMY
51%
Loosely correlated
+4.52%
SSMXY - TRUMY
46%
Loosely correlated
+0.80%
OLYMY - TRUMY
44%
Loosely correlated
-1.32%
GNNDY - TRUMY
33%
Poorly correlated
+4.33%
ESLOY - TRUMY
30%
Poorly correlated
+0.39%
More